Atopic Dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Pediatric patients with atopic dermatitis who have eczema on the elbow fossa with vIGA-AD score of 2 or higher
Exclusion criteria
Exclusion criteria: (1) Patients with a history of use of group II or higher topical steroids or delgocitinib ointment on the forearm within 1 month (2) Patients with signs of infection on the forearm (3) Patients with a history of use of biological drugs within 1 year or who are going to use biological drugs during participation in the study (4) Other patients deemed inappropriate as research subjects by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in TEWL and SCH from baseline to 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in TARC, SCCA2, EASI, pEASI and vIGA from baseline to 12 weeks TEWL, SCH, and questionnaire scores for eczematous and non-eczematous areas at 12 weeks TARC, SCCA2, EASI, pEASI and vIGA at 12 weeks EIS results at baseline and at 12 weeks, and findings from tape stripping | — |
Countries
Japan
Contacts
National Hospital Organization Sagamihara National Hospital Department of pediatrics